
DBV Technologies S.A. DBVT
$ 18.28
7.47%
Quarterly report 2025-Q2
added 07-29-2025
DBV Technologies S.A. P/S Ratio 2011-2026 | DBVT
Annual P/S Ratio DBV Technologies S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152 | 5.2 | 22.2 | 15.4 | - | - | - | - | - | 5.54 K | 3.71 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.54 K | 5.2 | 1.57 K |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
35.6 | $ 1.65 | 7.91 % | $ 92.9 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 93.52 | -1.2 % | $ 96.9 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.52 | -16.3 % | $ 388 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.59 | 1.99 % | $ 8.64 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Biogen
BIIB
|
2 | $ 184.48 | -1.67 % | $ 26.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 102.17 | 2.32 % | $ 27.2 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.25 | 1.67 % | $ 9.25 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 207.49 | 2.22 % | $ 5 B | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 10.84 | 0.46 % | $ 714 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
9.7 | $ 37.35 | -0.4 % | $ 3.86 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
4.96 | $ 23.18 | 2.02 % | $ 2.75 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 25.59 | -6.54 % | $ 1.65 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 4.22 | -4.2 % | $ 116 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 29.43 | 6.09 % | $ 1.43 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.66 | 2.28 % | $ 1.53 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 66.05 | 2.3 % | $ 8.83 B | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
2.6 K | $ 55.11 | 3.49 % | $ 4.45 B | ||
|
Abeona Therapeutics
ABEO
|
42.7 | $ 5.14 | -1.06 % | $ 110 M | ||
|
CRISPR Therapeutics AG
CRSP
|
89.5 | $ 55.17 | 2.47 % | $ 4.65 B | ||
|
Axon Enterprise
AXON
|
19.1 | $ 632.29 | 0.09 % | $ 47.9 B | ||
|
ADiTx Therapeutics
ADTX
|
0.442 | $ 0.81 | 1.96 % | $ 10.7 K | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.7 | 2.27 % | $ 17 M |